Diagnoses and Treatment Reports of 11 Cases of Primary Malignant Lymphoma of Prostate

Zheng Chen,Xin Li,Jue Wang,Yuhang Pan,Qiong Liang,Chunkui Shao,Xin Gao,Jun Pang
DOI: https://doi.org/10.3969/j.issn.1674-0904.2017.02.007
2017-01-01
Abstract:Objective: To investigate the clinical features and prognosis of primary malignant lymphoma of the prostate (PMLP).Methods: From November 2005 to December 2016, clinical, diagnose and pathologic data of eleven patients from the Third Affiliated Hospital of Sun Yat-sen University, the First Affiliated Hospital of Sun Yat-sen University and the Affiliated Hospital of Pingdingshan University were collected for analysis.Results: Lymphoma tended to occur in an elderly patient, with a mean age at diagnosis of 68 years (range: 57~82 years).The average serum prostate-specific antigen(PSA) levels and lactate dehydrogenase (LDH) levels were 2.68ng/ml (range: 0.54~4.82ng/ml) and 314.9 U/L(123.0~560.0 U/L), respectively.Computed tomography (CT) imaging demonstrated a large mass in the prostate, as well as obvious low urinary tract symptoms (LUTS) resulting from infiltration of the mass.Histological findings revealed diffuse large B-cell non-Hodgkin's lymphoma, including nine cases with diffuse large B-cell lymphoma and two cases of mantle cell lymphoma.The median survival time was 28 months, (range: 9~62 months), with six patients died of malignant lymphoma.Of them, 10 patients underwent surgery, 6 of them underwent subsequent CHOP or R-CHOP chemotherapy and 50% (3 of 6) displayed a survival time over 56 months.Conclusion: PMLP is a rare prostatic malignancy involving the prostate, which displayed few specific characteristic signs on laboratory tests (i.e.PSA and LDH) and CT examination.However, patients with PMLP respond well to chemotherapy, and combined treatment with operative intervention should be taken into account as LUTS could be cured by surgery.
What problem does this paper attempt to address?